LONDON, September 9, 2013 /PRNewswire/ --
Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, is today launching an awareness campaign to highlight the important work done by healthcare professionals.
Smith & Nephew has been supporting healthcare professionals for over 150 years. Today, the Company works with surgeons and nurses to provide life-changing treatments, to develop innovative products and, through the provision of medical education, to enhance skills and widen access to advanced medical technology. Smith & Nephew representatives see, first-hand, the extraordinary work these surgeons and nurses do, often in high-pressure, challenging situations, and has developed this campaign to highlight the crucial contribution these individuals make to society.
The campaign will launch with a series of advertisements in the UK & Ireland. These will feature in the national press and run on billboards. The advertisements are designed to increase public awareness of the important work these professionals do, and the skills they need to perform at the highest level.
Commenting on the launch, Smith & Nephew's Chief Executive Officer Olivier Bohuon said:
"Smith & Nephew is proud to support the vital role that surgeons and nurses play in society. They are highly skilled professionals facing intense pressures every day of their working lives. We make the products that help them do their job and they are essential in helping us innovate.
"Surgeons and nurses deserve our support and our respect. You can have the best products in the world but they are nothing without the right pair of hands to use them."
About Smith & Nephew
Smith & Nephew is a global medical technology business dedicated to helping improve people's lives. With leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma, Smith & Nephew has around 11,000 employees and a presence in more than 90 countries. Annual sales in 2012 were more than $4.1 billion. Smith & Nephew is a member of the FTSE100 (LSE: SN, NYSE: SNN).
For more information about Smith & Nephew, please visit: http://www.smith-nephew.com
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith & Nephew, these factors include: economic and financial conditions in the markets we serve, especially those affecting health care providers, payors and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls; litigation relating to patent or other claims; legal compliance risks and related investigative, remedial or enforcement actions; strategic actions, including acquisitions and dispositions, our success in integrating acquired businesses, and disruption that may result from changes we make in our business plans or organisation to adapt to market developments; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20-F, for a discussion of certain of these factors.
Any forward-looking statement is based on information available to Smith & Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith & Nephew are qualified by this caution. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith & Nephew's expectations.
à Trademark of Smith & Nephew. Registered US Patent and Trademark Office.
Enquiries: Media, Charles Reynolds, +44(0)20-7401-7646, Smith & Nephew; Andrew Mitchell / Justine McIlroy, +44(0)20-7404-5959, Brunswick; Investors, Phil Cowdy, +44(0)20-7401-7646, Smith & Nephew
SOURCE Smith & Nephew plc